⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 38 in last 7 days 🍎 Food: 116 in last 7 days 🧸 Products: 98 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 38 in last 7 days 🍎 Food: 116 in last 7 days 🧸 Products: 98 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
🇬🇧
💊 Medicine AT June 5, 2026

Haemoctin SDH 500 Pulver und Lösungsmittel zur Herstellung einer Injektionslösung 100 IE/ml (Pulver und Lösungsmittel zur Herstellung einer Injektionslösung)

📷 EU Safety Watch placeholder
Haemoctin SDH 500 Pulver und Lösungsmittel zur Herstellung einer Injektionslösung 100 IE/ml (Pulver und Lösungsmittel zur Herstellung einer Injektionslösung)
📷 EU Safety Watch placeholder
Haemoctin SDH 500 powder and solvent for injection solution 100 IU/ml is unavailable due to manufacturing capacity issues. Supply is expected to resume on 1 September 2026.
⚠️
Shortage ongoing
GERINNUNGSFAKTOR VIII is currently in short supply in AT.
📈 Timeline
5 days active so far
June 6, 2026 June 10, 2026

What is this? Haemoctin SDH is a powder and liquid that you mix to make an injection. It contains Factor VIII, a protein your body needs to help blood clot.

What's happening? The company cannot make enough of this medicine right now. It has been out of stock since June 2026 and is expected back in September 2026.

Does this affect me? If you use this medicine, you may not be able to get it until September 2026.

What should I do? Talk to your doctor or pharmacist about other treatment options until the medicine is available again.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

ATC: B02BD02 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Biotest Pharma GmbH, Landsteinerstraße 5, 63303 Dreieich, Federal Republic of Germany · Affected packs: 1 Stück Schachtel, Durchstechflasche, Durchstechflasche [Nicht verfügbar, since 2026-06-02, resupply 2026-09-01]

First published
June 5, 2026
Last refreshed by us
1 hour ago
Severity (as classified)
Low
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

❓ Frequently asked questions

What is this medicine shortage alert about?
Haemoctin SDH 500 Pulver und Lösungsmittel zur Herstellung einer Injektionslösung 100 IE/ml (Pulver und Lösungsmittel zur Herstellung einer Injektionslösung). Haemoctin SDH 500 powder and solvent for injection solution 100 IU/ml is unavailable due to manufacturing capacity issues. Supply is expected to resume on 1 September 2026.
When was this alert issued?
This alert was issued on June 5, 2026 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Low risk. A low risk means harm is unlikely under normal use. The alert is informational but still worth reading.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.